Bionova’s unique microencapsulation technology offers a wide variety of uses for food, beverage and nutraceutical product formulations. Other advantages of microencapsulation technology include: ...

Ottawa, Dec. 04, 2025 (GLOBE NEWSWIRE) -- The global microencapsulation technology market size is calculated at USD 8.17 billion in 2025 and is expected to reach around USD 16.43 billion by 2034, ...

Dublin, June 16, 2025 (GLOBE NEWSWIRE) -- The "Microencapsulation Market - Forecasts from 2025 to 2030" has been added to ResearchAndMarkets.com's offering. The global microencapsulation market, ...

Microencapsulation technology has revolutionized drug delivery systems, allowing for the protection and controlled release of therapeutic agents. Microcapsules, tiny spherical structures capable of ...

“Microencapsulation (as it applies to the food industry) is the process whereby various food ingredients can be stored within a microscopic size shell or coating for protection and/or later release.

Calyxia presents breakthrough microencapsulation technology during JEC Composites Connect Calyxia has developed a unique process to produce the first perfectly-sealed, process-resistant, and ...

RANCHO SANTA MARGARITA, CALIF. — Blue California offers FineCap, a microencapsulation technology platform for active ingredients. The platform was designed to help manufacturers utilize active ...

Particle Works has provided microencapsulation services for drug development applications, including controlled drug release, solubility enhancement or targeted drug delivery. Using its expertise in ...

CLEVELAND--(BUSINESS WIRE)--The Lubrizol Corporation, a specialty chemical company whose science delivers sustainable solutions to advance mobility, improve well-being, and enhance modern life, will ...

Danish start-up Mello is vying to advance current ‘state of art’ microencapsulation techniques after unveiling a new proprietary technology that it claims is able to better deliver functionally ...

MIRAMAR, Fla., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (OTCQB: GNBT) is pleased to announce that the Company has signed a binding letter of intent (LOI) to partner with ...